Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix †

Therapeutic vaccinations aim to re-educate human immunodeficiency virus (HIV)-1-specific immune responses to achieve durable control of HIV-1 replication in virally suppressed infected individuals after antiretroviral therapy (ART) is interrupted. In a double blinded, placebo-controlled phase IIa mu...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Wesley, Leal, Lorna, Buyze, Jozefien, Pannus, Pieter, Guardo, Alberto, Salgado, Maria, Mothe, Beatriz, Molto, Jose, Moron-Lopez, Sara, Gálvez, Cristina, Florence, Eric, Vanham, Guido, van Gorp, Eric, Brander, Christian, Allard, Sabine, Thielemans, Kris, Martinez-Picado, Javier, Plana, Montserrat, García, Felipe, Gruters, Rob A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963294/
https://www.ncbi.nlm.nih.gov/pubmed/31817794
http://dx.doi.org/10.3390/vaccines7040209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963294/
https://www.ncbi.nlm.nih.gov/pubmed/31817794
http://dx.doi.org/10.3390/vaccines7040209

Ejemplares similares